The major goal of the research plan is to complete the three-dimensional X-ray diffraction analysis of the E. coli protein elongation factor, Tu-GDP, and to utilize the new structural information to carry out a series of difference Fourier analyses on Tu-antibiotic complexes to elucidate the antibiotic binding site(s) on Tu. The completed structural determination at 2.8 Angstroms will result in a three-dimensional model of the protein, including the relative location of all amino acids along the polypeptide backbone and the location of the GDP binding site. The subsequent refinement of the protein structure at 2.35 Angstroms will provide an accurate description of the coordinates, conformation and interactions of all amino acids. Phase angles will be calculated from the final protein structure and applied to Fourier syntheses using, as coefficients, the difference between structure amplitudes for Tu-complexes and native Tu-GDP. A number of small molecules, including antibiotics, have successfully been diffused into crystals of Tu and diffraction data for one, a Tu-kirromycin complex, have been processed to a resolution of 2.7 Angstrom. X-ray diffraction data for other Tu-complex crystals, including the substrates, propidium iodide, tetracycline, streptomycin, puromycin, TPCK and ANS, will be collected during the grant period. An atomic description of all binding sites will be obtained by difference Fourier analyses and the results will provide a foundation for the rational design of antibiotics using Tu as a target site for the inhibition of bacterial protein biosynthesis. The refined structure of Tu will also be used as a basic model to study the atomic details of the conformational changes that occur in Tu during protein synthesis as the protein interacts with its allosteric effectors, GDP and GTP, and with other macromolecules, Ts and aminoacyl-tRNA. Large crystals of the Tu-Ts complex have been grown and a diffraction analysis will be initiated. The Tu-Ts structure will provide a molecular description of the interaction between the proteins and may suggest mechanisms for catalysis of guanine nucleotide exchange and for initiation of RNA synthesis in QB phage infection. New biochemical methods have been developed for the preparation of large quantities of the Tu-GTP-aminoacyl-tRNA complex and cocrystallization trials will resume. An X-ray diffraction analysis of the ternary complex would provide a direct visualization of a protein-nuclei acid interaction and may answer questions about Tu's ability to complex only to noninitiator, aminoacyl-tRNAs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM026895-07
Application #
3274351
Study Section
Biophysics and Biophysical Chemistry B Study Section (BBCB)
Project Start
1979-08-01
Project End
1988-11-30
Budget Start
1986-12-01
Budget End
1988-11-30
Support Year
7
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California Riverside
Department
Type
Earth Sciences/Resources
DUNS #
City
Riverside
State
CA
Country
United States
Zip Code
92521
Heffron, Susan E; Mui, Suet; Aorora, Annette et al. (2006) Molecular complementarity between tetracycline and the GTPase active site of elongation factor Tu. Acta Crystallogr D Biol Crystallogr 62:1392-400
Murase, Katsuyuki; Morrison, Kim L; Tam, Phillip Y et al. (2003) EF-Tu binding peptides identified, dissected, and affinity optimized by phage display. Chem Biol 10:161-8
Heffron, S E; Jurnak, F (2000) Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu. Biochemistry 39:37-45
Abel, K; Yoder, M D; Hilgenfeld, R et al. (1996) An alpha to beta conformational switch in EF-Tu. Structure 4:1153-9
Abel, K; Jurnak, F (1996) A complex profile of protein elongation: translating chemical energy into molecular movement. Structure 4:229-38
Manor, D; Weng, G Z; Deng, H et al. (1991) An isotope edited classical Raman difference spectroscopic study of the interactions of guanine nucleotides with elongation factor Tu and H-ras p21. Biochemistry 30:10914-20
Jurnak, F; Heffron, S; Schick, B et al. (1990) Three-dimensional models of the GDP and GTP forms of the guanine nucleotide domain of Escherichia coli elongation factor Tu. Biochim Biophys Acta 1050:209-14
Mui, S; Delaria, K; Jurnak, F (1990) Preliminary crystallographic analysis of a complex between tetracycline and the trypsin-modified form of Escherichia coli elongation factor Tu. J Mol Biol 212:445-7
Delaria, K; Jurnak, F (1989) Preparation of Escherichia coli elongation factor Tu-guanosine 5'-triphosphate analogs. Anal Biochem 177:188-93
McPherson, A; Jurnak, F; Singh, G J et al. (1987) Preliminary X-ray diffraction analysis of crystals of Bacillus thuringiensis toxin, a cell membrane disrupting protein. J Mol Biol 195:755-7

Showing the most recent 10 out of 15 publications